Aegon Ltd. New York Registry Shares (AEG)
FairStock Score: 47/100 — MIXED
Key Financials
| Current Price | $8.1 |
| Market Cap | $12.1B |
| P/E Ratio | 10.8 |
| ROE | 11.07% |
| Dividend Yield | 5.37% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At the close on 2026-10-13, Aegon traded at $8.33, with FairStock calculating an 11.11 earnings multiple and 1.20 times book. For an insurer earning an 11.07% return on equity, that is not outrageous; it is closer to fair than to bargain. The 5.37% dividend yield and 0.62 beta may appeal to income-minded investors, but I want more evidence before calling it a Buffett-style compounder. The business is diversified by geography and product—retirement, mutual funds, annuities, life and health—and brands like Transamerica and World Financial Group provide distribution scale. Still, insurance is competitive, and I see no hard proof of a durable moat in the supplied figures. The 0.10% ROCE is barely positive, and debt-to-equity of 0.43 is manageable but not trivial for a financial firm. The Piotroski F-score of 2/9 and FairStock score of 47/100 tell me the financial statement signals are weak. I also lack the metrics that matter most for an insurer: CET1, NIM and combined ratio are not in the data, so I cannot judge regulatory capital, spread income or underwriting profitability. Revenue and profit growth are listed as N/A, and the Lynch category is none because there are only zero years of filed results, versus the three needed. That makes earnings consistency impossible to verify. At 1.2 times book, the market is not paying a premium, but with an 11% ROE and no multi-year record, I would call Aegon a show-me story: reasonably priced, income-rich, but not demonstrably high quality.
In plain English: Aegon is a large insurer that sells life, health, retirement and annuity products, mainly under the Transamerica and World Financial Group names. It earns a moderate return on shareholder money, carries some debt, and pays a high dividend. At $8.33, the price looks roughly fair against its numbers, but there are some warning signs in the figures and missing history, so the business looks average rather than clearly strong.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer